Rely+On Virkon from LANXESS: highly effective against yeast Candida auris

  • Efficient prevention of drug resistant yeast
  • Disinfection as key measure to prevent infections
  • Effective even at short contact times
Cologne
Rely+On Virkon is a disinfectant for solid surfaces. It can be used at train stations, airports, hospitals, etc. to reduce the risk of contamination, e.g. with the coronavirus.
The broad spectrum disinfectant Rely+On Virkon from LANXESS has proven effective against the yeast Candida auris. Photo: LANXESS

The broad spectrum disinfectant Rely+On Virkon from specialty chemicals company LANXESS has proven effective against the yeast Candida auris. Thus, it can be used as disinfectant in healthcare and institutional facilities where an infection with the drug resistant yeast is either demonstrated, indeed suspected or should be prevented from the start. The disinfectant is effective at short contact times (0.75% in 5 minutes according to EN 1650) and enables hard surface disinfection and decontamination. In addition, it is also suitable for laboratory related applications.

Anneliese Bischof, Head of the Business Line CARE at LANXESS’ Material Protection Products business unit, says: “Practicing good hygiene must always be a part of our everyday routines, but the selection of a disinfectant proven to kill key pathogens is crucial.”

With cases of drug resistant pathogens continuing to cause significant concerns in healthcare facilities around the world, government health departments are providing advice and guidance on how to better prevent their transmission with hygiene and disinfection remaining of the utmost importance. The US CDC reports that 90 percent of Candida auris isolates are resistant to at least one antifungal medication, and 30 percent of them are resistant to at least two antifungal medications.

“Therefore, utilizing Rely+On Virkon as a surface disinfectant for the purposes of infection control can help to disinfect areas where a high risk of Candida auris transmission exists, and consequently reduce the risk of infection to patients, and both medical and laboratory staff,” Bischof concludes.

Further information can be found at www.relyondisinfection.com.

Information for editors:
All LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

You can find further information concerning LANXESS chemistry at http://lanxess.com/en/Media/Stories.

Rely+On Virkon from LANXESS: highly effective against yeast Candida auris

MORE ABOUT THIS TOPIC

PRESS RELEASE
Since August 1, 2013, specialty chemicals Group LANXESS is steering its global business from the LANXESS Tower in Cologne.

LANXESS increases sales and earnings in the third quarter of 2026

November 09, 2026
PRESS RELEASE
Woman put the cream on skin.

LANXESS Introduces Cosmelin Biodegradable Ester Portfolio for Cosmetics and Personal Care

October 26, 2026
PRESS RELEASE
Packshot Rely+On® Medero

LANXESS will present its new disinfectant, Rely+On Medero, for the first time at Medica 2026

October 22, 2026
PRESS RELEASE
Packshot Rely+On® Medero

LANXESS launches highly effective disinfectant for the medical sector

October 20, 2026
PRESS RELEASE
PIR insulation panel, aluminium-laminated

LANXESS sharpens flame-retardant portfolio for rigid PU and PIR insulation

September 22, 2026